SOMAmer technology to diagnose coronavirus infection: veterinary and zoonotic implications.

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: 2601029

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2021
    2025
  • Known Financial Commitments (USD)

    $0
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    UNIVERSITY OF OXFORD
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This project aims to research the development of a multiplex diagnostic Lateral Flow Device (LFD) to identify and differentiate coronavirus infections, aid more effective decision-making on interventions, and identify the occurrence and co-occurrence of infections from a single sample. This DPhil project will utilise aptamer technology, which is analogous to antibodies in function. Aptamers are oligonucleotides, small single-stranded DNA or RNA structures capable of specific binding to a selected protein target and therefore are ideal for diagnostic and therapeutic applications. Aptamers in addition offer further utility in terms of speed, cost, and flexibility in developing diagnostic tools compared to traditional monoclonal antibody applications. Furthermore, advanced highly modified DNA aptamers, specifically utilising SOMAmer technology (Slow off-rate modified aptamers) offer greater stability for long term storage.